You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

INI1 negative tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

Active, not recruiting
  • Malignant Rhabdoid Tumors (MRT)
  • +10 more
  • San Francisco, California
  • +31 more
Jan 17, 2023

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

Rhabdoid Tumors, INI1-negative Tumors, Synovial Sarcoma Trial in Worldwide (Tazemetostat)

Completed
  • Rhabdoid Tumors
  • +3 more
  • Los Angeles, California
  • +34 more
Dec 23, 2021

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

Not yet recruiting
  • Advanced Solid Tumor
  • +8 more
  • (no location specified)
Nov 13, 2023

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Ovarian Cancer, Melanoma, Triple Negative Breast Cancer Trial (NM1F Injection, Pembrolizumab injection)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • NM1F Injection
  • Pembrolizumab injection
  • (no location specified)
Feb 23, 2023

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Breast Cancer Trial in Guangzhou (BL-M02D1)

Recruiting
  • Breast Cancer
  • Bengbu, Anhui, China
  • +9 more
Jan 11, 2023

Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

Completed
Has Results
  • Metastatic Breast Cancer
  • Solid Tumors
  • Aurora, Colorado
    University of Colorado Cancer Center
May 17, 2022

Breast Cancer Trial in Tucson (Rucaparib)

Active, not recruiting
  • Breast Cancer
  • Tucson, Arizona
    University of Arizona Cancer Center
Feb 24, 2022

Solid Tumors, ER+ Breast Cancer, Triple Negative Breast Cancer, TNBC Trial (JAB-2485 (Aurora A inhibitor))

Not yet recruiting
  • Solid Tumors
  • +4 more
  • JAB-2485 (Aurora A inhibitor)
  • (no location specified)
Aug 4, 2022

Solid Tumor, Adult, Triple Negative Breast Cancer, Colorectal Cancer Trial in Scottsdale, La Jolla, Stanford (CRX100 suspension

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • CRX100 suspension for infusion
  • Scottsdale, Arizona
  • +2 more
Jul 26, 2022

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in Boston, Galveston,

Suspended
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Boston, Massachusetts
  • +2 more
Oct 5, 2022

Advanced Solid Tumors or Triple-negative Breast Cancer Trial in Japan (Sacituzumab Govitecan-hziy)

Recruiting
  • Advanced Solid Tumors or Triple-negative Breast Cancer
  • Sacituzumab Govitecan-hziy
  • Aichi, Japan
  • +21 more
Dec 1, 2022

Non Small Cell Lung Cancer, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RTX-224)

Terminated
  • Non Small Cell Lung Cancer
  • +4 more
  • Scottsdale, Arizona
  • +4 more
Dec 7, 2022

Triple Negative Breast Cancer, Breast Cancer, Endometrial Cancer Trial in New York, Fairfax, Spokane (XMT-1660)

Recruiting
  • Triple Negative Breast Cancer
  • +5 more
  • Orange, California
  • +6 more
Jan 23, 2023

Head and Neck Squamous Cell Carcinoma, Melanoma Excluding Uveal Melanoma, NSCLC, Squamous or Non-squamous Trial in Denver,

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +8 more
  • XmAb®808
  • Keytruda® (pembrolizumab)
  • Denver, Colorado
  • +2 more
Jan 19, 2023

Non Small Cell Lung Cancer, Urothelial Cancer, Ovarian Cancer Trial in United States (XB002, Nivolumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +9 more
  • Saint Louis, Missouri
  • +4 more
Dec 12, 2022

Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

Suspended
  • Solid Tumor
  • ARID1A Gene Mutation
  • Greenville, South Carolina
    Prisma Health Cancer Institute
Jan 10, 2023

Urothelial Carcinoma, Triple Negative Breast Cancer, NSCLC Trial (SBT6290, pembrolizumab)

Withdrawn
  • Urothelial Carcinoma
  • +4 more
  • (no location specified)
Apr 4, 2022

Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in United States (PRO1184)

Recruiting
  • Ovarian Cancer
  • +8 more
  • Scottsdale, Arizona
  • +11 more
Jan 31, 2023

Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, NSCLC Trial in United States (LYL797)

Recruiting
  • Triple Negative Breast Cancer
  • +14 more
  • LYL797
  • Scottsdale, Arizona
  • +10 more
Jan 30, 2023

Melanoma (Skin), Triple-Negative Breast Cancer, NSCLC Trial (PeptiCRAd-1, Cyclophosphamide, Pembrolizumab)

Not yet recruiting
  • Melanoma (Skin)
  • +2 more
  • (no location specified)
Aug 5, 2022